AJCN North Carolina Research Campus
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Martínez-Chantar, M L.
Right arrow Articles by Mato, J. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Martínez-Chantar, M L.
Right arrow Articles by Mato, J. M
Agricola
Right arrow Articles by Martínez-Chantar, M L.
Right arrow Articles by Mato, J. M
American Journal of Clinical Nutrition, Vol. 76, No. 5, 1177S-1182S, November 2002
© 2002 American Society for Clinical Nutrition


Supplements

Importance of a deficiency in S-adenosyl-L-methionine synthesis in the pathogenesis of liver injury1,2,3,4

M Luz Martínez-Chantar, Elena R García-Trevijano, M Ujue Latasa, Isabel Pérez-Mato, Manuel M Sánchez del Pino, Fernando J Corrales, Matias A Avila and José M Mato

1 From the Division of Hepatology and Gene Therapy, School of Medicine, University of Navarra, Pamplona, Spain.

One of the features of liver cirrhosis is an abnormal metabolism of methionine—a characteristic that was described more than a half a century ago. Thus, after an oral load of methionine, the rate of clearance of this amino acid from the blood is markedly impaired in cirrhotic patients compared with that in control subjects. Almost 15 y ago we observed that the failure to metabolize methionine in cirrhosis was due to an abnormally low activity of the enzyme methionine adenosyltransferase (EC 2.5.1.6). This enzyme converts methionine, in the presence of ATP, to S-adenosyl-L-methionine (SAMe), the main biological methyl donor. Since then, it has been suspected that a deficiency in hepatic SAMe may contribute to the pathogenesis of the liver in cirrhosis. The studies reviewed here are consistent with this hypothesis.

Key Words: Methionine • S-adenosyl-l-methionine • SAMe • methionine adenosyltransferase • liver injury • liver regeneration • cirrhosis • oxidative stress • protein S-nitrosylation




This article has been cited by other articles:


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
A. Sahai, P. Malladi, H. Melin-Aldana, R. M. Green, and P. F. Whitington
Upregulation of osteopontin expression is involved in the development of nonalcoholic steatohepatitis in a dietary murine model
Am J Physiol Gastrointest Liver Physiol, July 1, 2004; 287(1): G264 - G273.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
C. S Lieber and L. Packer
S-Adenosylmethionine: molecular, biological, and clinical aspects--an introduction
Am. J. Clinical Nutrition, November 1, 2002; 76 (5): 1148S - 1150S.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Clin. Nutr.Home page
D. Mischoulon and M. Fava
Role of S-adenosyl-L-methionine in the treatment of depression: a review of the evidence
Am. J. Clinical Nutrition, November 1, 2002; 76 (5): 1158S - 1161S.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by The American Society for Nutrition